{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T17:48:18Z","timestamp":1786297698778,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.msard.2022.103677","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T01:40:59Z","timestamp":1644975659000},"page":"103677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Prevalence of neuromyelitis optica spectrum disorder in antioquia between 2016 and 2018"],"prefix":"10.1016","volume":"60","author":[{"given":"Carolina","family":"Monsalve Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Pati\u00f1o L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5358-8635","authenticated-orcid":false,"given":"Carolina","family":"Restrepo-Aristiz\u00e1bal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"Zuluaga Rodas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Herrera Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra Patricia","family":"Isaza Jaramillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Andr\u00e9s","family":"Jim\u00e9nez Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.msard.2022.103677_bib0001","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Bennett","year":"2015","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.msard.2022.103677_bib0002","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11910-014-0483-3","article-title":"Neuromyelitis optica spectrum disorders","volume":"14","author":"Flanagan","year":"2014","journal-title":"Curr. Neurol. Neurosci. Rep."},{"issue":"3","key":"10.1016\/j.msard.2022.103677_bib0003","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1212\/CON.0000000000000742","article-title":"Neuromyelitis optica spectrum disorder and other non\u2013multiple sclerosis central nervous system inflammatory diseases","volume":"25","author":"Flanagan","year":"2019","journal-title":"Contin. Lifelong Learn. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2022.103677_bib0004","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7861\/clinmedicine.19-2-169","article-title":"Neuromyelitis optica spectrum disorders","volume":"19","author":"Huda","year":"2019","journal-title":"Clin. Med."},{"issue":"3","key":"10.1016\/j.msard.2022.103677_bib0005","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/WCO.0000000000000551","article-title":"Mechanisms for lesion localization in neuromyelitis optica spectrum disorders","volume":"31","author":"Bradl","year":"2018","journal-title":"Curr. Opin. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2022.103677_bib0006","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/brain\/awz054","article-title":"Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders","volume":"142","author":"Palace","year":"2019","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.msard.2022.103677_bib0007","first-page":"e504","article-title":"Apheresis therapies for NMOSD attacks","volume":"5","author":"Kleiter","year":"2018","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2022.103677_bib0008","first-page":"250","article-title":"Treatment of neuromyelitis optica spectrum disorders","volume":"31","author":"Romeo","year":"2019","journal-title":"Curr. Opin. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2022.103677_bib0009","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.autrev.2018.01.001","article-title":"Diagnosis and management of neuromyelitis optica spectrum disorders - an update","volume":"17","author":"Bruscolini","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"501","key":"10.1016\/j.msard.2022.103677_bib0010","article-title":"Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide","volume":"11","author":"Hor","year":"2020","journal-title":"Front. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2022.103677_bib0011","first-page":"1","article-title":"Epidemiology of neuromyelitis optica in Latin America","volume":"3","author":"Alvarenga","year":"2017","journal-title":"Mult. Scler. J."},{"issue":"5","key":"10.1016\/j.msard.2022.103677_bib0012","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s00415-008-0781-2","article-title":"Characteristics of Devic \u2019 s disease (neuromyelitis optica) in Mexico","volume":"255","author":"Rivera","year":"2008","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2022.103677_bib0013","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000443834","article-title":"Prevalence of dystonia in Antioquia, Colombia","volume":"46","author":"Atehort\u00faa","year":"2016","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.msard.2022.103677_bib0014","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.33588\/rn.3112.2000492","article-title":"Prevalencia de la esclerosis m\u00faltiple en Colombia","volume":"31","author":"S\u00e1nchez","year":"2000","journal-title":"Rev. Neurol."},{"issue":"11","key":"10.1016\/j.msard.2022.103677_bib0015","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.33588\/rn.3411.2001523","article-title":"Prevalencia de miastenia gravis en Antioquia, Colombia","volume":"34","author":"S\u00e1nchez","year":"2002","journal-title":"Rev. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2022.103677_bib0016","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/00207450490269444","article-title":"Prevalence of Parkinson's disease and parkinsonism in a Colombian population using the capture-recapture method","volume":"114","author":"S\u00e1nchez","year":"2004","journal-title":"Int. J. Neurosci."},{"issue":"3","key":"10.1016\/j.msard.2022.103677_bib0017","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000504549","article-title":"Prevalence, incidence, and clinical-epidemiological characterization of amyotrophic lateral sclerosis in Antioquia: Colombia","volume":"54","author":"Zapata-Zapata","year":"2020","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.msard.2022.103677_bib0018","unstructured":"DANE Departamento Administrativo Nacional de Estad\u00edstica (2018). Censo General 2018 [docu- mento en l\u00ednea]. Disponible en http:\/\/www.dane. gov.co\/daneweb_V09\/index.php?option=com_ content&view=article&id=307&Itemid=124."},{"issue":"20","key":"10.1016\/j.msard.2022.103677_bib0019","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World medical association declaration of Helsinki: ethical principles for medical involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.msard.2022.103677_bib0020","unstructured":"Colombia M de Salud. Resoluci\u00f3n n\u00famero 8430 de 1993. 1993."},{"issue":"20","key":"10.1016\/j.msard.2022.103677_bib0022","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1002\/sim.996","article-title":"The applications of capture-recapture models to epidemiological data","volume":"20","author":"Chao","year":"2001","journal-title":"Stat. Med."},{"issue":"3","key":"10.1016\/j.msard.2022.103677_bib0023","doi-asserted-by":"crossref","first-page":"190","DOI":"10.22379\/2422402296","article-title":"Espectro de neuromielitis \u00f3ptica en Colombia, primera caracterizaci\u00f3n cl\u00ednico imagenol\u00f3gica en tres centros de Bogot\u00e1","volume":"32","author":"Reyes","year":"2016","journal-title":"Acta Neurol. Colomb."},{"issue":"8","key":"10.1016\/j.msard.2022.103677_bib0024","first-page":"1039","article-title":"Effects of age and sex on aquaporin-4 autoimmunity","volume":"69","author":"Quek","year":"2013","journal-title":"Arch. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.msard.2022.103677_bib0025","first-page":"7","article-title":"Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: a review","volume":"355","author":"De Carvalho","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2022.103677_bib0021","article-title":"Organizaci\u00f3n Panamericana de la Salud y Consejo de Organizaciones Internacionales de las Ciencias M\u00e9dica. Pautas \u00e9ticas internacionales para la investigaci\u00f3n relacionada con la salud con seres humanos, Cuarta Edici\u00f3n","year":"2016","journal-title":"Ginebra: Consejo de Organizaciones Internacionales de las Ciencias M\u00e9dicas (CIOMS)"},{"issue":"2","key":"10.1016\/j.msard.2022.103677_bib0026","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1212\/WNL.0000000000011153","article-title":"Worldwide incidence and prevalence of NMO: a systematic review","volume":"96","author":"Palace","year":"2021","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2022.103677_bib0027","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41572-020-0214-9","article-title":"Neuromyelitis optica","volume":"6","author":"Jarius","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"5","key":"10.1016\/j.msard.2022.103677_bib0028","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/ana.24617","article-title":"Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum","volume":"79","author":"Flanagan","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2022.103677_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/174720","article-title":"Epidemiology of neuromyelitis optica in the world: a systematic review and meta-analysis","volume":"2015","author":"Etemadifar","year":"2015","journal-title":"Mult. Scler. Int."},{"issue":"8","key":"10.1016\/j.msard.2022.103677_bib0030","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11926-016-0599-3","article-title":"Neuromyelitis optica (Devic \u2019 s syndrome): an appraisal","volume":"18","author":"Crout","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.msard.2022.103677_bib0031","article-title":"Epidemiological findings of neuromyelitis optica spectrum disorders in a Venezuelan study","volume":"47","author":"De Castillo","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"7","key":"10.1016\/j.msard.2022.103677_bib0032","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1177\/1352458515572406","article-title":"Demographic and clinical features of neuromyelitis optica: a review","volume":"21","author":"Pandit","year":"2015","journal-title":"Mult. Scler. J."},{"issue":"18","key":"10.1016\/j.msard.2022.103677_bib0033","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1212\/WNL.0b013e3182190f74","article-title":"A population-based study of neuromyelitis optica in Caucasians","volume":"76","author":"Asgari","year":"2011","journal-title":"Neurology"},{"issue":"24","key":"10.1016\/j.msard.2022.103677_bib0034","doi-asserted-by":"crossref","first-page":"e2265","DOI":"10.1212\/WNL.0000000000006645","article-title":"Nationwide prevalence and incidence study of neuromyelitis optica spectrum disorder in Denmark","volume":"91","author":"Papp","year":"2018","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.msard.2022.103677_bib0035","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1468-1331.2011.03529.x","article-title":"The prevalence of neuromyelitis optica in South East Wales","volume":"19","author":"Cossburn","year":"2012","journal-title":"Eur. J. Neurol."},{"issue":"14","key":"10.1016\/j.msard.2022.103677_bib0036","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1177\/1352458517735191","article-title":"Epidemiology of NMOSD in Catalonia\u00a0: influence of the new 2015 criteria in incidence and prevalence estimates","volume":"24","author":"Sep\u00falveda","year":"2018","journal-title":"Mult. Scler. J."},{"issue":"12","key":"10.1016\/j.msard.2022.103677_bib0037","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1177\/1352458514521503","article-title":"Prevalence and patterns of demyelinating central nervous system disorders in urban","volume":"20","author":"Pandit","year":"2014","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2022.103677_bib0038","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1212\/WNL.0000000000004611","article-title":"Prevalence and clinical features of neuromyelitis optica spectrum disorders in northern Japan","volume":"89","author":"Houzen","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2022.103677_bib0039","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.msard.2017.10.007","article-title":"Neuromyelitis optica spectrum disorders in Iran","volume":"18","author":"Eskandarieh","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"17","key":"10.1016\/j.msard.2022.103677_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3346\/jkms.2020.35.e115","article-title":"Prevalence and incidence of neuromyelitis optica spectrum disorder in Korea\u00a0: population based study","volume":"35","author":"Lee","year":"2020","journal-title":"J. Korean Med. Sci."},{"issue":"8","key":"10.1016\/j.msard.2022.103677_bib0041","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/jnnp-2016-314839","article-title":"Incidence and prevalence of NMOSD in Australia and New Zealand","volume":"88","author":"Bukhari","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.msard.2022.103677_bib0042","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00415-009-0009-0","article-title":"An epidemiological study of neuromyelitis optica in Cuba","volume":"256","author":"Cabrera-G\u00f3mez","year":"2009","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2022.103677_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.102807","article-title":"Prevalence of neuromyelitis optica spectrum disorder in Belo Horizonte, Southeast Brazil","volume":"50","author":"Lana-Peixoto","year":"2021","journal-title":"Mult. Scler. Relat. Disord."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822001924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034822001924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T09:01:58Z","timestamp":1761901318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034822001924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":43,"alternative-id":["S2211034822001924"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2022.103677","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of neuromyelitis optica spectrum disorder in antioquia between 2016 and 2018","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2022.103677","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103677"}}